Monkeypox breakthrough infections and side-effects: Clarion call for nex-gen novel vaccine
Ranjan K. Mohapatra,
Snehasish Mishra,
Ali A. Rabaan,
Aroop Mohanty,
Bijaya Kumar Padhi,
Ranjit Sah
Affiliations
Ranjan K. Mohapatra
Corresponding author.; Department of Chemistry, Government College of Engineering, Keonjhar, 758002, Odisha, India
Snehasish Mishra
School of Biotechnology, Campus-11, KIIT Deemed-to-be-University, Bhubaneswar, 751024, Odisha, India
Ali A. Rabaan
Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, 31311, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, 11533, Saudi Arabia; Department of Public Health and Nutrition, The University of Haripur, Haripur, 22610, Pakistan
Aroop Mohanty
Department of Microbiology, All India Institute of Medical Sciences, Gorakhpur, India
Bijaya Kumar Padhi
Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, India
Ranjit Sah
Corresponding author. Infectious Diseases Fellowship, Clinical Research (Harvard Medical School), Global Clinical Scholars Research Training (Harvard Medical School), SRMA (London School of Hygiene and Tropical Medicine), Kathmandu, 44600, Nepal.; Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal; Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India; Harvard Medical School, Boston, MA, 02115, USA
